Lifitegrast

Product NDC
59651-450
11-digit product format
596510450
Labeler code
59651
Product ID
59651-450_1d4b4b61-79da-4b6f-bb19-056d111bf400
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lifitegrast
Dosage form
FOR SOLUTION
Route
OPHTHALMIC
Labeler
Aurobindo Pharma Limited
Application
ANDA215063
Marketing category
ANDA
Marketing start
2023-11-07
Substance
LIFITEGRAST
Active strength
50 mg/mL
Pharmacologic classes
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Lifitegrast
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LIFITEGRAST50 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii038E5L962W
Rxcui1801835

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
ef78cb32-15f8-4d2d-9107-ca3997b019cfProduct name120160819
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59651-450-05Lifitegrast0.2 mL in 1 AMPULEFOR SOLUTION0.21
59651-450-05Lifitegrast5 in 1 POUCHFOR SOLUTION51
59651-450-60Lifitegrast60 in 1 CARTONFOR SOLUTION601

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59651-450LIFITEGRAST FOR SOLUTION [AUROBINDO PHARMA LIMITED]1Current NDC, 3 package rows20231115_1d4b4b61-79da-4b6f-bb19-056d111bf400.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1801835lifitegrast 5 % Ophthalmic SolutionPSN1d4b4b61-79da-4b6f-bb19-056d111bf4001
1801835lifitegrast 50 MG/ML Ophthalmic SolutionSCD1d4b4b61-79da-4b6f-bb19-056d111bf4001
1801835lifitegrast 5 % Ophthalmic SolutionSY1d4b4b61-79da-4b6f-bb19-056d111bf4001

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
59651-450-05596510450050.2 mL in 1 AMPULE0.2 mlHistorical
59651-450-605965104506060 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE60 pouch2023-11-07NoNoHistorical